{"id":28611,"date":"2016-08-03T03:59:34","date_gmt":"2016-08-03T10:59:34","guid":{"rendered":"http:\/\/lifeboat.com\/blog\/2016\/08\/google-is-developing-bioelectronic-medicines-to-try-and-cure-chronic-illnesses"},"modified":"2017-06-04T14:28:06","modified_gmt":"2017-06-04T21:28:06","slug":"google-is-developing-bioelectronic-medicines-to-try-and-cure-chronic-illnesses","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2016\/08\/google-is-developing-bioelectronic-medicines-to-try-and-cure-chronic-illnesses","title":{"rendered":"Google is Developing \u2018Bioelectronic Medicines\u2019 to Try And Cure Chronic Illnesses"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/google-is-developing-bioelectronic-medicines-to-try-and-cure-chronic-illnesses.jpg\"><\/a><\/p>\n<p>Verily and GlaxoSmithKline have partnered to form Galvani Bioelectronics, a new company which will focus on the research, development, and commercialization of bioelectronics. One of the first projects will be to develop a precision device that can fix type 2 diabetes.<\/p>\n<p><a href=\"https:\/\/verily.com\/\" target=\"_blank\">Verily<\/a>, formerly known as Google Life Sciences, is partnering with GlaxoSmithKline (GSK) to develop bioelectronic medicines that can \u201charness electrical signals in the body to treat chronic disease.\u201d<\/p>\n<p>The collaboration marries GSK\u2019s pharmaceutical expertise with Verily\u2019s prowess in developing tiny low power electronics. The unification will result in a new company called Galvani Bioelectronics, after Italian scientist Luigi Aloisio Galvani who was an early pioneer of bioelectricity.<\/p>\n<p><!-- Link: <a href=\"http:\/\/futurism.com\/google-is-developing-bioelectronic-medicines-to-try-and-cure-chronic-illnesses\/\">http:\/\/futurism.com\/google-is-developing-bioelectronic-medic...illnesses\/<\/a> --><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Verily and GlaxoSmithKline have partnered to form Galvani Bioelectronics, a new company which will focus on the research, development, and commercialization of bioelectronics. One of the first projects will be to develop a precision device that can fix type 2 diabetes. Verily, formerly known as Google Life Sciences, is partnering with GlaxoSmithKline (GSK) to develop [\u2026]<\/p>\n","protected":false},"author":367,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,1694],"tags":[],"class_list":["post-28611","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-electronics"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/28611","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/367"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=28611"}],"version-history":[{"count":3,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/28611\/revisions"}],"predecessor-version":[{"id":66690,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/28611\/revisions\/66690"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=28611"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=28611"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=28611"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}